UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
Crew of fatal US military crash included Alabama father recently deployed
The six U.S. service members who died in the crash of a U.S. military refueling aircraft included an Alabama father who had just been promoted and deployed. The U.S. government released the identities of the deceased service members Saturday.
Alabama poised to drastically overhaul utility regulation. Will it lower electric bills?
The Alabama Senate unanimously voted to expand the public service commission, and create a Secretary of Energy to address rising electricity prices. A bill in the House would go even further, requiring rate case hearings and limiting utility profits.
Musher from Alabama is going for back-to-back Iditarod wins
Riches and paid appearances haven’t followed Jessie Holmes since he won the world’s most famous sled dog race, the Iditarod, last year. He doesn't mind.
Bill would move Alabama to closed primaries
Right now, any Alabama voter can participate in a primary election. Lawmakers in Montgomery took up a bill this week that would change that system.
Auburn football player uses NIL funds to open a community hub in Birmingham
Jourdin Crawford, a freshman defensive lineman at Auburn, used earnings from a Name, Image, and Likeness deal to give back to his hometown.
Ivey commutes death sentence of inmate whose accomplice fired fatal shot
Charles “Sonny” Burton was sentenced to death for the killing of Doug Battle during a 1991 robbery. However, another man shot Battle when Burton had left the building.
